Form 8-K - Current report:
SEC Accession No. 0001728117-25-000004
Filing Date
2025-02-19
Accepted
2025-02-19 16:01:12
Documents
13
Period of Report
2025-02-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K goss-20250219.htm   iXBRL 8-K 28694
  Complete submission text file 0001728117-25-000004.txt   150729

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20250219.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20250219_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20250219_pre.xml EX-101.PRE 12516
15 EXTRACTED XBRL INSTANCE DOCUMENT goss-20250219_htm.xml XML 2813
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 25639771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)